Insider · CIK 0001534002
Angus C. Russell
Files at LCTX (Lineage Cell Therapeutics, Inc.), GPCR (Structure Therapeutics Inc.). First filing -, latest -.
In brief
Angus C. Russell files SEC Form 4 as director at LCTX (Lineage Cell Therapeutics, Inc.), and also at GPCR (Structure Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Angus C. Russell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jul 2, 2026 |
| Jun 17, 2026 | GPCR Structure Therapeutics Inc. | AGrant or award Share Option (right to buy)derivative | +39,453 | $0.00 | $0 | 39,453 | Jun 18, 2026 |
| Jul 1, 2025 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jul 2, 2025 |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award Share Option (right to buy)derivative | +42,833 | $0.00 | $0 | 42,833 | Jun 25, 2025 |
Questions about Angus C. Russell
Answered from the filings on this page, as of the latest one.
Is Angus C. Russell buying or selling?
Angus C. Russell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Angus C. Russell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Angus C. Russell has 0.
Where does Angus C. Russell file Form 4?
Angus C. Russell has filed Form 4 at LCTX (Lineage Cell Therapeutics, Inc.); GPCR (Structure Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.